Angi, Inc. (ANGI) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1245826,
    "name": "Angi, Inc.",
    "stock_name": "Angi, Inc.",
    "full_name": "Angi, Inc.",
    "name_url": "stocks-analysis/angi-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "12.97",
    "chg": 0.96,
    "chgp": "7.99%",
    "dir": 1,
    "prev_price": "12.01",
    "mcapval": "887.15",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Computers - Software & Consulting",
    "ind_code": 3320,
    "indexname": "S&P 500",
    "isin": "US00183L1026",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "2.11 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/angi-inc-1245826-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Angi, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-angi-inc-overvalued-or-undervalued-3738264",
        "imagepath": "",
        "date": "2025-12-01 11:06:09",
        "description": "As of 28 November 2025, the valuation grade for Angi, Inc. has moved from fair to expensive, indicating that the stock is overvalued. The company exhibits a P/E ratio of 16, a Price to Book Value of 0.81, and an EV to EBITDA of 8.45, which suggests that the stock is trading at a premium compared to its earnings and book value. \n\nIn comparison to peers, Angi, Inc. has a P/E ratio of 14.77, while GoodRx Holdings, Inc. stands out with a much higher P/E of 31.76, indicating a significant valuation disparity. Additionally, eGain Corp. shows a P/E of 6.67, further emphasizing Angi's expensive valuation relative to its peers. Although specific return data is not available, the lack of recent performance metrics against the S&P 500 reinforces the notion that Angi, Inc. may not be a compelling investment at its current valuation...."
      },
      {
        "title": "Is Angi, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-angi-inc-overvalued-or-undervalued-3737292",
        "imagepath": "",
        "date": "2025-11-30 11:06:25",
        "description": "As of 28 November 2025, the valuation grade for Angi, Inc. has moved from fair to expensive, indicating a shift towards overvaluation. The company appears overvalued based on its P/E ratio of 16, which is higher than the industry average, and an EV to EBITDA ratio of 8.45, which suggests a premium compared to peers. Additionally, the Price to Book Value stands at 0.81, reflecting a relatively low valuation against its book value.\n\nIn comparison to its peers, Angi, Inc. has a P/E ratio of 14.77, while GoodRx Holdings, Inc. shows a much higher P/E of 31.76, indicating that Angi is not only overvalued but also less attractive than some competitors. The return comparison with the S&P 500 is not available, but the current valuation metrics reinforce the conclusion that Angi, Inc. is overvalued in the current market context...."
      },
      {
        "title": "Is Angi, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-angi-inc-overvalued-or-undervalued-3689292",
        "imagepath": "",
        "date": "2025-11-11 11:34:28",
        "description": "As of 7 November 2025, the valuation grade for Angi, Inc. has moved from expensive to fair. Based on the current metrics, Angi appears to be fairly valued. Key ratios include a P/E ratio of 16, a Price to Book Value of 0.81, and an EV to EBITDA of 8.45. In comparison to peers, Angi's P/E ratio of 14.77 is more attractive than Sharecare, Inc. which is risky with a P/E of -5.08, and GoodRx Holdings, Inc. which is fair with a P/E of 31.76.\n\nWhile specific return data is not available, the overall valuation suggests that Angi, Inc. is positioned reasonably within its industry, especially when compared to its peers...."
      },
      {
        "title": "Is Angi, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-angi-inc-overvalued-or-undervalued-3683196",
        "imagepath": "",
        "date": "2025-11-09 11:09:32",
        "description": "As of 7 November 2025, the valuation grade for Angi, Inc. has moved from expensive to fair. Based on the current metrics, the company appears to be fairly valued. Key ratios include a P/E ratio of 16, a Price to Book Value of 0.81, and an EV to EBITDA of 8.45. \n\nIn comparison to peers, Angi, Inc. has a more attractive P/E ratio of 14.77 than GoodRx Holdings, Inc. at 31.76 and eGain Corp. at 6.67. The PEG ratio of 0.01 suggests significant growth potential relative to its earnings. Although specific return data is not available, the overall performance of Angi, Inc. should be considered in the context of the S&P 500, reinforcing the notion that the stock is currently fairly valued...."
      },
      {
        "title": "Is Angi, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-angi-inc-technically-bullish-or-bearish-3651473",
        "imagepath": "",
        "date": "2025-10-28 11:44:06",
        "description": "As of 24 October 2025, the technical trend for Angi, Inc. has changed from sideways to mildly bearish. The weekly MACD is bearish, while the monthly MACD shows a mildly bullish stance, indicating mixed signals across time frames. The Bollinger Bands are mildly bearish on the weekly and bearish on the monthly, reinforcing the bearish outlook. Moving averages are mildly bullish on the daily, suggesting short-term strength, but the overall weekly indicators, including KST and OBV, are mildly bearish. There is no available return data to compare the company's performance against the S&P 500. Overall, the current technical stance is mildly bearish, driven by the predominance of bearish indicators on the weekly timeframe...."
      },
      {
        "title": "Is Angi, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-angi-inc-technically-bullish-or-bearish-3647925",
        "imagepath": "",
        "date": "2025-10-27 11:55:13",
        "description": "As of 24 October 2025, the technical trend for Angi, Inc. has changed from sideways to mildly bearish. The weekly MACD is bearish, while the monthly MACD shows a mildly bullish stance. The Bollinger Bands indicate a mildly bearish trend on the weekly chart and bearish on the monthly chart. Moving averages present a mildly bullish signal on the daily timeframe, but the KST and OBV are both mildly bearish on the weekly and monthly charts. Overall, the indicators suggest a mildly bearish stance, with the weekly metrics weighing more heavily. There is no available return data to compare the company's performance against the S&P 500...."
      },
      {
        "title": "Is Angi, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-angi-inc-technically-bullish-or-bearish-3646458",
        "imagepath": "",
        "date": "2025-10-26 11:29:59",
        "description": "As of 24 October 2025, the technical trend for Angi, Inc. has changed from sideways to mildly bearish. The weekly MACD is bearish, while the monthly MACD shows a mildly bullish stance. The Bollinger Bands indicate a mildly bearish trend on the weekly chart and bearish on the monthly chart. Moving averages are mildly bullish on the daily timeframe, but the KST and OBV are both mildly bearish on the weekly and monthly charts. Overall, the technical stance is mildly bearish, driven primarily by the bearish signals from the MACD and Bollinger Bands on the weekly timeframe. Multi-period return data is not available for comparison with the S&P 500...."
      },
      {
        "title": "Is Angi, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-angi-inc-overvalued-or-undervalued-3637874",
        "imagepath": "",
        "date": "2025-10-21 12:10:45",
        "description": "As of 17 October 2025, the valuation grade for Angi, Inc. has moved from very attractive to attractive. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 16, a Price to Book Value of 0.81, and an EV to EBITDA of 8.45, which suggest that Angi, Inc. is positioned competitively within its industry.\n\nIn comparison to peers, Angi, Inc. has a lower P/E ratio than GoodRx Holdings, Inc. at 31.76 and a more favorable EV to EBITDA ratio than eGain Corp. at 23.15. While the company has shown some resilience, the lack of recent return data makes it difficult to assess its performance against the S&P 500. Overall, Angi, Inc. is fairly valued in the current market context...."
      },
      {
        "title": "Is Angi, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-angi-inc-overvalued-or-undervalued-3634747",
        "imagepath": "",
        "date": "2025-10-20 12:28:03",
        "description": "As of 17 October 2025, the valuation grade for Angi, Inc. has moved from very attractive to attractive. Based on the current metrics, Angi appears to be fairly valued. The P/E ratio stands at 16, while the EV to EBITDA ratio is 8.45, and the Price to Book Value is 0.81. These ratios suggest that the company is positioned reasonably within its industry.\n\nIn comparison to peers, Angi, Inc. has a P/E ratio of 14.77, which is lower than GoodRx Holdings, Inc. at 31.76, indicating that Angi may be undervalued relative to this competitor. Additionally, eGain Corp., which is rated attractive, has a significantly lower EV to EBITDA ratio of 23.15, further highlighting Angi's competitive positioning. Although return data is not available, the stock's performance relative to the S&P 500 could provide further context to its valuation narrative...."
      }
    ],
    "total": 18,
    "sid": "1245826",
    "stock_news_url": "https://www.marketsmojo.com/news/angi-inc-1245826"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Angi, Inc. overvalued or undervalued?

2025-12-01 11:06:09

As of 28 November 2025, the valuation grade for Angi, Inc. has moved from fair to expensive, indicating that the stock is overvalued. The company exhibits a P/E ratio of 16, a Price to Book Value of 0.81, and an EV to EBITDA of 8.45, which suggests that the stock is trading at a premium compared to its earnings and book value. In comparison to peers, Angi, Inc. has a P/E ratio of 14.77, while GoodRx Holdings, Inc. stands out with a much higher P/E of 31.76, indicating a significant valuation disparity. Additionally, eGain Corp. shows a P/E of 6.67, further emphasizing Angi's expensive valuation relative to its peers. Although specific return data is not available, the lack of recent performance metrics against the S&P 500 reinforces the notion that Angi, Inc. may not be a compelling investment at its current valuation....

Is Angi, Inc. overvalued or undervalued?

2025-11-30 11:06:25

As of 28 November 2025, the valuation grade for Angi, Inc. has moved from fair to expensive, indicating a shift towards overvaluation. The company appears overvalued based on its P/E ratio of 16, which is higher than the industry average, and an EV to EBITDA ratio of 8.45, which suggests a premium compared to peers. Additionally, the Price to Book Value stands at 0.81, reflecting a relatively low valuation against its book value. In comparison to its peers, Angi, Inc. has a P/E ratio of 14.77, while GoodRx Holdings, Inc. shows a much higher P/E of 31.76, indicating that Angi is not only overvalued but also less attractive than some competitors. The return comparison with the S&P 500 is not available, but the current valuation metrics reinforce the conclusion that Angi, Inc. is overvalued in the current market context....

Is Angi, Inc. overvalued or undervalued?

2025-11-11 11:34:28

As of 7 November 2025, the valuation grade for Angi, Inc. has moved from expensive to fair. Based on the current metrics, Angi appears to be fairly valued. Key ratios include a P/E ratio of 16, a Price to Book Value of 0.81, and an EV to EBITDA of 8.45. In comparison to peers, Angi's P/E ratio of 14.77 is more attractive than Sharecare, Inc. which is risky with a P/E of -5.08, and GoodRx Holdings, Inc. which is fair with a P/E of 31.76. While specific return data is not available, the overall valuation suggests that Angi, Inc. is positioned reasonably within its industry, especially when compared to its peers....

Is Angi, Inc. overvalued or undervalued?

2025-11-09 11:09:32

As of 7 November 2025, the valuation grade for Angi, Inc. has moved from expensive to fair. Based on the current metrics, the company appears to be fairly valued. Key ratios include a P/E ratio of 16, a Price to Book Value of 0.81, and an EV to EBITDA of 8.45. In comparison to peers, Angi, Inc. has a more attractive P/E ratio of 14.77 than GoodRx Holdings, Inc. at 31.76 and eGain Corp. at 6.67. The PEG ratio of 0.01 suggests significant growth potential relative to its earnings. Although specific return data is not available, the overall performance of Angi, Inc. should be considered in the context of the S&P 500, reinforcing the notion that the stock is currently fairly valued....

Is Angi, Inc. technically bullish or bearish?

2025-10-28 11:44:06

As of 24 October 2025, the technical trend for Angi, Inc. has changed from sideways to mildly bearish. The weekly MACD is bearish, while the monthly MACD shows a mildly bullish stance, indicating mixed signals across time frames. The Bollinger Bands are mildly bearish on the weekly and bearish on the monthly, reinforcing the bearish outlook. Moving averages are mildly bullish on the daily, suggesting short-term strength, but the overall weekly indicators, including KST and OBV, are mildly bearish. There is no available return data to compare the company's performance against the S&P 500. Overall, the current technical stance is mildly bearish, driven by the predominance of bearish indicators on the weekly timeframe....

Is Angi, Inc. technically bullish or bearish?

2025-10-27 11:55:13

As of 24 October 2025, the technical trend for Angi, Inc. has changed from sideways to mildly bearish. The weekly MACD is bearish, while the monthly MACD shows a mildly bullish stance. The Bollinger Bands indicate a mildly bearish trend on the weekly chart and bearish on the monthly chart. Moving averages present a mildly bullish signal on the daily timeframe, but the KST and OBV are both mildly bearish on the weekly and monthly charts. Overall, the indicators suggest a mildly bearish stance, with the weekly metrics weighing more heavily. There is no available return data to compare the company's performance against the S&P 500....

Is Angi, Inc. technically bullish or bearish?

2025-10-26 11:29:59

As of 24 October 2025, the technical trend for Angi, Inc. has changed from sideways to mildly bearish. The weekly MACD is bearish, while the monthly MACD shows a mildly bullish stance. The Bollinger Bands indicate a mildly bearish trend on the weekly chart and bearish on the monthly chart. Moving averages are mildly bullish on the daily timeframe, but the KST and OBV are both mildly bearish on the weekly and monthly charts. Overall, the technical stance is mildly bearish, driven primarily by the bearish signals from the MACD and Bollinger Bands on the weekly timeframe. Multi-period return data is not available for comparison with the S&P 500....

Is Angi, Inc. overvalued or undervalued?

2025-10-21 12:10:45

As of 17 October 2025, the valuation grade for Angi, Inc. has moved from very attractive to attractive. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 16, a Price to Book Value of 0.81, and an EV to EBITDA of 8.45, which suggest that Angi, Inc. is positioned competitively within its industry. In comparison to peers, Angi, Inc. has a lower P/E ratio than GoodRx Holdings, Inc. at 31.76 and a more favorable EV to EBITDA ratio than eGain Corp. at 23.15. While the company has shown some resilience, the lack of recent return data makes it difficult to assess its performance against the S&P 500. Overall, Angi, Inc. is fairly valued in the current market context....

Is Angi, Inc. overvalued or undervalued?

2025-10-20 12:28:03

As of 17 October 2025, the valuation grade for Angi, Inc. has moved from very attractive to attractive. Based on the current metrics, Angi appears to be fairly valued. The P/E ratio stands at 16, while the EV to EBITDA ratio is 8.45, and the Price to Book Value is 0.81. These ratios suggest that the company is positioned reasonably within its industry. In comparison to peers, Angi, Inc. has a P/E ratio of 14.77, which is lower than GoodRx Holdings, Inc. at 31.76, indicating that Angi may be undervalued relative to this competitor. Additionally, eGain Corp., which is rated attractive, has a significantly lower EV to EBITDA ratio of 23.15, further highlighting Angi's competitive positioning. Although return data is not available, the stock's performance relative to the S&P 500 could provide further context to its valuation narrative....

View All News